Literature DB >> 26528700

Intravenous Lidocaine Infusion to Treat Chemotherapy-Induced Peripheral Neuropathy.

Peter Papapetrou1, Aashish J Kumar, Rudram Muppuri, Shushovan Chakrabortty.   

Abstract

Chemotherapy-induced peripheral neuropathy is a debilitating side effect of chemotherapy, which manifests as paresthesias, dysesthesias, and numbness in the hands and feet. Numerous chemoprotective agents and treatments have been used with limited success to treat chemotherapy-induced peripheral neuropathy. We report a case in which a patient presenting with chemotherapy-induced peripheral neuropathy received an IV lidocaine infusion over the course of 60 minutes with complete symptomatic pain relief for a prolonged period of 2 weeks.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26528700     DOI: 10.1213/XAA.0000000000000197

Source DB:  PubMed          Journal:  A A Case Rep        ISSN: 2325-7237


  4 in total

Review 1.  Role of Intravenous Lidocaine Infusion in the Treatment of Peripheral Neuropathy.

Authors:  Harshit Gupta; Anjana Patel; Zahaan Eswani; Peyton Moore; Mattie Steib; Christopher Lee; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2021-07-11

Review 2.  Chemotherapy-Related Neurotoxicity.

Authors:  Sophie Taillibert; Emilie Le Rhun; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

Review 3.  Lidocaine Infusions for Pain Management in Pediatrics.

Authors:  Elizabeth A Hall; Hannah E Sauer; Margaret S Davis; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2021-05-26       Impact factor: 3.930

4.  Lidocaine infusions and reduced opioid consumption-Retrospective experience in pediatric hematology and oncology patients with refractory pain.

Authors:  Doralina L Anghelescu; Kyle J Morgan; Michael J Frett; Diana Wu; Yimei Li; Yuanyuan Han; Elizabeth A Hall
Journal:  Pediatr Blood Cancer       Date:  2021-07-15       Impact factor: 3.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.